• First BeNeBio publication
    Recently, a manuscript of the BeNeBio study protocol was published in BMC Trials. You might access the paper here: Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study—the BeNeBio study. Lisa Schots also presented the study protocol in a poster … Read more
  • BeNeBio study – 2021
    On behalf of the BeNeBio study team we wish everyone a happy and healthy 2021. We will look forward to further collaborations with all involved parties, because ‘together we make BeNeBio work’!
  • Start first Belgian hospitals
    Currently, the first Belgian hospitals have been started with the BeNeBio study. This means that also in Belgium the first patients have been included for participation in the study!
  • Start BeNeBio study
    After a delay due to COVID19, in August the first patients started with the BeNeBio study in the Radboudumc. The preparations for study start in the other participating centres are ongoing. We expect that the first patients in the other centres can be included soon!
  • Preparations BeNeBio study
    Preparations for the start of the BeNeBio study are ongoing. Local approval from the medical ethical committee in the Netherlands is received. Local approvals for all participating sites is being requested. Due to COVID-19, the start of the study will be delayed.